Marie-Luise Kruse

Author PubWeight™ 29.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene 2003 2.96
2 Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta. Cancer Res 2004 2.19
3 Expression of stem cell markers in human astrocytomas of different WHO grades. J Neurooncol 2007 1.46
4 No evidence of transdifferentiation of human endothelial progenitor cells into cardiomyocytes after coculture with neonatal rat cardiomyocytes. Circulation 2006 1.39
5 Inhibition of TNF receptor 1 internalization by adenovirus 14.7K as a novel immune escape mechanism. J Clin Invest 2006 1.20
6 Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin. J Invest Dermatol 2007 1.13
7 Human EML4, a novel member of the EMAP family, is essential for microtubule formation. Exp Cell Res 2006 1.13
8 Different properties of VEGF-antagonists: Bevacizumab but not Ranibizumab accumulates in RPE cells. Graefes Arch Clin Exp Ophthalmol 2009 1.09
9 Interaction with factor associated with neutral sphingomyelinase activation, a WD motif-containing protein, identifies receptor for activated C-kinase 1 as a novel component of the signaling pathways of the p55 TNF receptor. J Immunol 2002 1.04
10 IEX-1 directly interferes with RelA/p65 dependent transactivation and regulation of apoptosis. Biochim Biophys Acta 2007 1.03
11 Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis. J Pathol 2005 1.01
12 Bone marrow-derived pancreatic stellate cells in rats. Cell Res 2010 0.93
13 Increased intestinal permeability and tight junction disruption by altered expression and localization of occludin in a murine graft versus host disease model. BMC Gastroenterol 2011 0.93
14 Expression of lymphangiogenic factors and evidence of intratumoral lymphangiogenesis in pancreatic endocrine tumors. Am J Pathol 2004 0.92
15 Expression of mutated cationic trypsinogen reduces cellular viability in AR4-2J cells. Biochem Biophys Res Commun 2005 0.90
16 repp86: A human protein associated in the progression of mitosis. Mol Cancer Res 2003 0.89
17 Inflammatory macrophages induce Nrf2 transcription factor-dependent proteasome activity in colonic NCM460 cells and thereby confer anti-apoptotic protection. J Biol Chem 2011 0.89
18 alpha5-integrin is crucial for L1CAM-mediated chemoresistance in pancreatic adenocarcinoma. Int J Oncol 2009 0.87
19 LOXL4 is a selectively expressed candidate diagnostic antigen in head and neck cancer. Eur J Cancer 2008 0.87
20 The early response gene IEX-1 attenuates NF-kappaB activation in 293 cells, a possible counter-regulatory process leading to enhanced cell death. Oncogene 2003 0.86
21 Adjuvant treatment of pancreatic carcinoma in a clinically adapted mouse resection model. Pancreatology 2006 0.83
22 Immediate early gene-X1 interferes with 26 S proteasome activity by attenuating expression of the 19 S proteasomal components S5a/Rpn10 and S1/Rpn2. Biochem J 2007 0.83
23 Establishment of a novel orthotopic xenograft model of human gallbladder carcinoma. Clin Exp Metastasis 2007 0.81
24 Specific regulation of low-abundance transcript variants encoding human Acyl-CoA binding protein (ACBP) isoforms. J Cell Mol Med 2011 0.78
25 Terminally modified oligodeoxynucleotides directed against p53 in an orthotopic xenograft model: a novel adjuvant treatment strategy for pancreatic ductal carcinoma. Pancreas 2004 0.78
26 The outwardly rectifying chloride channel in rat peritoneal mast cells is regulated by serine/threonine kinases and phosphatases. Pflugers Arch 2001 0.77
27 Regulation of repp86 stability by human Siah2. Biochem Biophys Res Commun 2007 0.77
28 Characterisation of FAP-1 expression and CD95 mediated apoptosis in the A818-6 pancreatic adenocarcinoma differentiation system. Differentiation 2011 0.75
29 Characterisation of a novel matrix metalloproteinase inhibitor on pancreatic adenocarcinoma cells in vitro and in an orthotopic pancreatic cancer model in vivo. Int J Oncol 2008 0.75
30 Upregulation of p21(WAF1/Cip1) precedes tumor necrosis factor-induced necrosis-like cell death. Biochem Biophys Res Commun 2002 0.75
31 Efficient dose-dependent and time-dependent protein transduction of pancreatic carcinoma cells in vitro and in vivo using purified VP22-EGFP fusion protein. J Mol Med (Berl) 2003 0.75
32 A modified random oligonucleotide-based combination therapy for adjuvant treatment of pancreatic ductal adenocarcinoma. Int J Oncol 2006 0.75